We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

The right ingredients

10 January 2011 By Chris Hughes

Shares in the Danish enzymes group briefly rose above the value of its U.S. suitor’s offer. But with an auction having already taken place, and the exit multiple looking stretched, hopes of a counterbid are optimistic. Still, it’s a reminder that corporates have appetite for M&A.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)